Juul Labs suffers 23% revenue drop in Q1 2022

Jul.21.2022
Juul Labs suffers 23% revenue drop in Q1 2022
Juul Labs Inc. reported a 23% revenue drop and $28 million loss in Q1 2022, amid pressure from government regulators.

According to insiders, Juul Labs Inc. suffered a loss in the first quarter of 2022, with revenue dropping by 23% compared to the previous year. The company has been trying to regain public trust during the government's crackdown on youth vaping.


According to sources, Juul presented financial data during its search for rescue financing. As of March 31st, Juul generated revenue of $259 million in the first quarter, with a pre-adjustment loss of $28 million due to interest, taxes, depreciation, and amortization. In the same period last year, the company reported revenue of $29 million.


Due to regulatory efforts to crack down on underage e-cigarette use, Juul is facing increasing sales pressure. In June, the FDA banned the placement of Juul products on shelves in the United States, citing a lack of evidence demonstrating the overall safety of the company's products and noting Juul's disproportionate role in the rise of youth e-cigarette use. Juul then won an emergency court order, temporarily halting the decision and allowing the company to continue selling its products. Juul is also facing a series of consumer lawsuits that could result in millions of dollars in damages.


The company is currently attempting to raise funds in order to gain some breathing room prior to several repayment deadlines.


According to unnamed sources, Juul currently has $323 million in cash on hand as of the first quarter, which is lower than the $428 million they had during the same period last year. Their total debt amounts to around $2.15 billion, which includes a $394 million term loan due in August 2023 and approximately $1.7 billion in "physically settled securities" notes due in 2025 that allow the company to defer interest payments.


Consideration of bankruptcy.


In addition to considering financing options, the company has been exploring various alternatives, including filing for bankruptcy. According to a Bloomberg report earlier this month, Kirkland & Ellis and Alvarez & Marsal have been providing Juul with litigation and restructuring advice.


The potential ban by the FDA is part of a long-running movement by the government to control electronic cigarette manufacturers. Flavorings such as mango and crème brûlée have helped Juul's founders become billionaires, and seem to be aimed at attracting young customers, despite the company's claims that its products offer a safer way for smokers to consume nicotine.


In 2019, Juul ceased the sale of most flavors, and the following year, the FDA prohibited the entry of sweet and fruity flavors into the market.


A spokesperson for Juul has stated that the company is exploring alternative financing options in light of ongoing FDA scrutiny and has yet to decide on any particular course of action. The statement also affirms the company's commitment to providing their product to adult consumers seeking an alternative to traditional cigarettes.


Translate into standard journalistic English:


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Juul, NJOY and Altria Clash Over Use of UCSF Public Documents in U.S. Patent Litigation
Juul, NJOY and Altria Clash Over Use of UCSF Public Documents in U.S. Patent Litigation
Juul Labs has asked a U.S. federal court to prevent NJOY and Altria from using documents stored in a public UCSF database in an ongoing patent lawsuit, arguing they are protected by attorney–client privilege. The defendants say the files have long been public and may contain evidence relevant to Juul’s patent conduct.
Dec.29 by 2FIRSTS.ai
Imperial Brands names John Rishton chair-designate, to take over as chair in December 2026
Imperial Brands names John Rishton chair-designate, to take over as chair in December 2026
Imperial Brands said in a statement on its website that John Rishton will join the board in July 2026 and assume the role of chair in December, succeeding current chair Thérèse Esperdy, who will retire at that time.
Jan.21 by 2FIRSTS.ai
China’s E-Cigarette Exports Fall Slightly to USD 10.6 Billion in 2025, U.S. Market Further Consolidates Lead
China’s E-Cigarette Exports Fall Slightly to USD 10.6 Billion in 2025, U.S. Market Further Consolidates Lead
China’s e-cigarette exports totaled approximately USD 10.60 billion in 2025, down 3.3% year-on-year from USD 10.96 billion in 2024, according to annual trade data released by the General Administration of Customs of China. Despite the mild decline, exports remained firmly above the USD 10 billion mark, with a clear rebound in the fourth quarter.
Jan.20 by 2FIRSTS.ai
Exclusive: Suspected ‘Backend Update Then Withdrawal’ Suggests Glas May Be Next FDA-Authorized E-Cigarette Brand After Juul
Exclusive: Suspected ‘Backend Update Then Withdrawal’ Suggests Glas May Be Next FDA-Authorized E-Cigarette Brand After Juul
An exclusive 2Firsts investigation found an unpublished FDA update on e-cigarette marketing authorizations that mirrors market speculation, suggesting Glas’s application may have cleared internal review, though no official confirmation has been issued.
Regulations
Dec.21
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Altria on December 19 confirmed that six on! PLUS nicotine pouch products had received U.S. FDA marketing authorization, ending a PMTA review lasting more than a year after the company moved ahead with launch plans before clearance.
Regulations
Dec.20
Australia’s TGA Seizes Illicit Vaping Products Worth Over  US$670,000 in Bendigo
Australia’s TGA Seizes Illicit Vaping Products Worth Over US$670,000 in Bendigo
Australia’s Therapeutic Goods Administration (TGA) has seized illicit vaping products with an estimated street value exceeding A$1 million (approximately US$670,000) following an enforcement operation in Bendigo, Victoria.
Dec.24 by 2FIRSTS.ai